Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
5-methyl-1-(phenyl-d5)pyridin-2(1H)-one
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
No -Refer MSDS for accurate information
Pirfenidone-d5 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Pirfenidone-d5 usage and description
Pirfenidone-d5 is a deuterated form of Pirfenidone, a medication used to treat idiopathic pulmonary fibrosis (IPF), a chronic and progressive lung disease that causes scarring of lung tissue. Pirfenidone-d5 is a labeled compound with deuterium, a stable isotope of hydrogen. This labeling does not change the therapeutic properties of Pirfenidone but allows for more accurate analysis of its pharmacokinetics and pharmacodynamics.
Pirfenidone-d5 works by reducing inflammation and inhibiting the production of fibroblasts, cells that produce collagen and contribute to the formation of scar tissue in the lungs. This medication has been shown to slow down the progression of IPF, improving lung function and quality of life for patients.
In terms of chemical information, Pirfenidone-d5 has a molecular formula of C12H3D5NO and a molecular weight of 202.28 g/mol. Its chemical structure is similar to that of Pirfenidone, with the addition of five deuterium atoms. This labeling allows for more precise analysis of the drug's absorption, distribution, metabolism, and excretion in the body.
Overall, Pirfenidone-d5 is a valuable tool in the study of Pirfenidone's pharmacokinetics and pharmacodynamics, and its use in research may lead to a better understanding of its therapeutic properties and potential new treatments for IPF.
